Novartis Investigative Site

Minato, Tokyo 108-0014

0 studies enrolling now · 1 studies all time

What they study most

Chronic Spontaneous Urticaria

Studies at this site

• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib — Running, not enrolling